XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jul. 30, 2022
Jan. 29, 2022
Jul. 31, 2021
Current Assets:      
Cash $ 44,939 $ 320,525 $ 304,039
Accounts receivable, net of allowances of $5,335 at July 30, 2022, $4,656 at January 29, 2022 and $4,440 at July 31, 2021 42,782 39,509 31,872
Inventories 507,236 278,200 326,477
Prepaids and other current assets 99,455 71,564 91,554
Total current assets 694,412 709,798 753,942
Property and equipment, net 220,742 216,308 202,711
Operating lease right of use assets 491,412 543,789 610,188
Goodwill 38,523 38,556 38,787
Other intangibles 27,506 29,855 31,063
Deferred income taxes 4,519 1,466 0
Other noncurrent assets 22,606 22,327 21,929
Total Assets 1,499,720 [1] 1,562,099 1,658,620 [2]
Current Liabilities:      
Accounts payable 226,779 152,484 186,593
Current portion - operating lease liabilities 135,571 145,088 156,562
Other accrued liabilities 80,266 134,156 134,407
Total current liabilities 442,616 431,728 477,562
Long-term debt 48,872 15,679 20,022
Long-term operating lease liabilities 413,416 471,878 524,857
Other long-term liabilities 34,283 40,346 48,082
Total liabilities 939,187 959,631 1,070,523
Commitments and contingent liabilities
Equity      
Non-redeemable preferred stock 818 827 828
Common equity:      
Common stock, $1 par value: Authorized; 80,000,000 shares Issued common stock 13,557 14,256 15,597
Additional paid-in capital 298,010 291,444 286,298
Retained earnings 307,929 350,206 336,659
Accumulated other comprehensive loss (41,924) (36,408) (33,428)
Treasury shares, at cost (488,464 shares) (17,857) (17,857) (17,857)
Total equity 560,533 602,468 588,097
Total Liabilities and Equity $ 1,499,720 $ 1,562,099 $ 1,658,620
[1] Of our $712.2 million of long-lived assets, $93.7 million and $21.5 million relate to long-lived assets in the U.K. and Canada, respectively.
[2] Of our $812.9 million of long-lived assets, $129.4 million and $30.3 million relate to long-lived assets in the U.K. and Canada, respectively.